Lombard Medical Technologies PLC Holding(s) in Company (5955H)
June 21 2013 - 6:23AM
UK Regulatory
TIDMLMT
RNS Number : 5955H
Lombard Medical Technologies PLC
21 June 2013
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i)
--------------------------------------------------
1. Identity of the issuer or the underlying Lombard Medical Technologies PLC
issuer
of existing shares to which voting rights
are
attached: (ii)
-------------------------------------------------- -----------------------------------
2. Reason for the notification (please tick the appropriate box or boxes):
---------------------------------------------------------------------------------------
An acquisition or disposal of voting rights X
------------------------------------------------------------------------------ -------
An acquisition or disposal of qualifying financial instruments
which may result in the acquisition of shares already issued to
which voting rights are attached
------------------------------------------------------------------------------ -------
An acquisition or disposal of instruments with similar economic
effect to qualifying financial instruments
------------------------------------------------------------------------------ -------
An event changing the breakdown of voting rights
------------------------------------------------------------------------------ -------
Other (please
specify):
------------------ ---------------------------------------------------------- -------
3. Full name of person(s) subject Abingworth LLP
to the Abingworth Bioventures V Co-Invest
notification obligation: (iii) Growth Equity Fund LP ("AGE")
------------------------------------------ -------------------------------------------
4. Full name of shareholder(s) Bank of New York (Nominees) Limited
(if different from 3.):(iv) (as nominee for AGE)
------------------------------------------ -------------------------------------------
5. Date of the transaction and date 17 June 2013
on
which the threshold is crossed
or
reached: (v)
------------------------------------------ -------------------------------------------
6. Date on which issuer notified: 20 June 2013
------------------------------------------ -------------------------------------------
7. Threshold(s) that is/are crossed Below 11%--AGE
or Below 18%--Abingworth LLP
reached: (vi, vii)
------------------------------------------ -------------------------------------------
8. Notified details: Abingworth LLP
------------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
------------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the triggering
of to the triggering transaction
shares transaction
if possible
using
the ISIN CODE
--------------- ------------------------------------ -----------------------------------------------------------------
Number Number Number Number of voting % of voting rights
of of of rights (x)
Shares Voting shares
Rights
--------------- --------------- ------------------- --------- ----------------------- -----------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
--------------- ---- ------- ------ ----- ---- --------- ----------- ---------- ------------- --------------
Lombard
Medical
Technologies
PLC
ISIN
(GB00B0Q5QP56)
20p Ords 5,714,285 7,984,725 17.85%
--------------- ------------------- --------- ----------- ---------- ------------- --------------
B: Qualifying Financial Instruments
------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
------------------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date (xiii) Conversion Period rights that may rights
(xiv) be
acquired if the
instrument is
exercised/ converted.
----------------------- --------------- --------------------------- --------------------------- --------------------
C: Financial Instruments with similar economic effect to Qualifying Financial
Instruments (xv, xvi)
------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
------------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting rights
financial price date (xvii) Conversion rights instrument (xix, xx)
instrument period refers to
(xviii)
----------------- ------------- ------------- --------------- --------------------------- -------------------------
Nominal Delta
----------------- ------------- ------------- --------------- --------------------------- ------------ -----------
Total (A+B+C)
------------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
-------------------------------------------------------------- --------------------------------------------------------
7,984,725 17.85%
-------------------------------------------------------------- --------------------------------------------------------
8. Notified details: Abingworth Bioventures V Co-Invest Growth Equity
Fund LP
--------------------------------------------------------------------------------------------------------------------------
A: Voting rights attached to shares (viii, ix)
--------------------------------------------------------------------------------------------------------------------------
Class/type Situation previous Resulting situation after the triggering
of to the triggering transaction
shares transaction
if possible
using
the ISIN CODE
--------------- ---------------------------------- ---------------------------------------------------------------------
Number Number Number Number of voting % of voting rights
of of of shares rights (x)
Shares Voting
Rights
--------------- -------------- ------------------ ------------ ----------------------- ------------------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
--------------- --- ------- ------ ----- --- ------------ ------------ --------- --------------- -------------
Lombard
Medical
Technologies
PLC
ISIN
(GB00B0Q5QP56)
20 p Ords 3,428,571 3,428,571 4,790,835 4,790,835 10.71%
-------------- ------------------ ------------ ------------ --------- --------------- -------------
B: Qualifying Financial Instruments
--------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
--------------------------------------------------------------------------------------------------------------------------
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date (xiii) Conversion Period rights that may rights
(xiv) be
acquired if the
instrument is
exercised/ converted.
---------------------- --------------- ----------------------------- ----------------------------- -------------------
C: Financial Instruments with similar economic effect to Qualifying Financial
Instruments (xv, xvi)
--------------------------------------------------------------------------------------------------------------------------
Resulting situation after the triggering transaction
--------------------------------------------------------------------------------------------------------------------------
Type of Exercise Expiration Exercise/ Number of voting % of voting rights
financial price date (xvii) Conversion rights instrument (xix, xx)
instrument period refers to
(xviii)
----------------- ------------ ------------- ----------------- ---------------------------- -------------------------
Nominal Delta
----------------- ------------ ------------- ----------------- ---------------------------- ------------- ----------
Total (A+B+C)
--------------------------------------------------------------------------------------------------------------------------
Number of voting rights Percentage of voting rights
--------------------------------------------------------------- ---------------------------------------------------------
4,790,835 10.71%
--------------------------------------------------------------- ---------------------------------------------------------
9. Chain of controlled undertakings through which the voting rights and/or
the
financial instruments are effectively held, if applicable: (xxi)
--------------------------------------------------------------------------------------------------------------------------
Abingworth Bioventures V Co-Invest Growth Equity Fund LP (which holds
4,790,835 shares in the company (10.71%)) and Abingworth Bioventures
V LP (which holds 3,193,890 shares in the company (7.14%)) are both managed
by Abingworth LLP.
Proxy Voting:
--------------------------------------------------------------------------------------------------------------------------
10. Name of the proxy holder:
------------------------------------------------------------------------------- -----------------------------------------
11. Number of voting rights proxy holder will
cease
to hold:
------------------------------------------------------------------------------- -----------------------------------------
12. Date on which proxy holder will cease to
hold
voting rights:
------------------------------------------------------------------------------- -----------------------------------------
13. Additional information:
--------------------------------------------------------------- ---------------------------------------------------------
14. Contact name: John Heard
--------------------------------------------------------------- ---------------------------------------------------------
15. Contact telephone number: 0207 534 1500
--------------------------------------------------------------- ---------------------------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUAURRORANUAR
Lombard Medical Technologies (LSE:LMT)
Historical Stock Chart
From May 2024 to Jun 2024
Lombard Medical Technologies (LSE:LMT)
Historical Stock Chart
From Jun 2023 to Jun 2024
